Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Physician Training for Florbetapir-PET Interpretation
NCT01565382Phase 3Completed
- Sponsor
- Avid Radiopharmaceuticals
- Start
- Feb 2011
- Primary completion
- Feb 2011
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of florbetapir (18F) in Alzheimer's disease (AD), Mild Cognitive Impairment (MCI), sponsored by Avid Radiopharmaceuticals. Started Feb 2011; status: completed.
02
Drugs
florbetapir (18F)
03
Conditions
Alzheimer's disease (AD)Mild Cognitive Impairment (MCI)
Beyond the preview
Go deeper on NCT01565382.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01565382.